Quantcast

Latest FDA Stories

2014-06-03 16:25:04

HORSHOLM, Denmark, June 3, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced the hiring of senior level management in preparation for potential U.S. commercialization of Envarsus(®) XR (tacrolimus extended-release tablets) an investigational new drug under FDA review for the prevention of organ rejection in adult kidney transplant patients. Key points: -- Envarsus( )XR is an extended release formulation of tacrolimus being designed for once-daily...

2014-06-03 12:37:09

SILVER SPRING, Md., June 3, 2014 /PRNewswire-USNewswire/ -- FDA's Read the Label Youth Outreach Campaign is an exciting initiative that challenges kids (ages 9 to 13) to "get their food facts first" by using the Nutrition Facts Label to make healthy food choices. Read the Label campaign materials enable parents and caregivers to help kids use this important tool. To view the multimedia assets associated with this release, please click:...

2014-06-03 12:20:52

BRENTWOOD, Tenn., June 3, 2014 /PRNewswire/ -- OHL, a leading global 3PL provider, announced today that it has met all Food and Drug Administration (FDA) validation requirements for its primary warehouse management system (WMS) Synapse. http://photos.prnewswire.com/prnvar/20110708/CL31865LOGO "The validation of our WMS shows we are committed to meeting the quality and regulatory requirements that come with healthcare," said Shawn MacCartey, OHL Senior Vice President, Healthcare....

2014-06-03 08:32:29

Multi-Tranche Financing Provides Sufficient Funding to Take KP201 Through and Beyond Potential FDA Approval and Enables KemPharm to Advance its Full Pipeline of Abuse-Deterrent Prodrugs CORALVILLE, Iowa, June 3, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that it has entered into a $60 million financing agreement with an investment fund managed by...

2014-06-03 08:32:20

First U.S. Installs of Next-generation Breast Imaging Technology at Fairfax Radiological Breast Diagnostic Imaging Center in D.C. and Phelps Memorial Hospital in NY MILWAUKEE, June 3, 2014 /PRNewswire/ -- GE Healthcare today announced FDA approval and the U.S. launch of their new breast imaging technology, the Invenia(TM) ABUS, proven to help clinicians find 35.7% more cancers in women with dense breasts than mammograms alone(1). In keeping with a strong commitment to furthering the...

2014-06-02 23:10:38

polyDNA’s May 2014 survey revealed that 14% of elderly respondents wanted to know if a common virus could cause inflammatory bowel disease. polyDNA reviews the literature and recommends taking Gene-Eden-VIR or Novirin. Rochester, NY (PRWEB) June 02, 2014 polyDNA’s latest survey discovered that some older participants wanted to know if a common virus could cause inflammatory bowel disease. The answer is “yes.” The cytomegalovirus (CMV) can cause inflammation of the colon. This is a...

2014-06-02 23:10:09

On May 23, the FDA notified of a critical shortage of Sterrad Cyclesure 24 Biological Indicators due to a machine performance issue on Advanced Sterilization Products production line. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) June 02, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts...

2014-06-02 12:28:53

BERLIN, June 2, 2014 /PRNewswire/ -- GE Healthcare and Fiagon AG Announce a Patent License AgreementFiagon AG today announced that it has entered into an agreement with GE Healthcare. Under the terms of the agreement, Fiagon will acquire a patent license to several of GE Healthcare's ENT and Cranial navigation technologies. This will help Fiagon surround and back up the 35 issued patents and substantial intellectual property of Fiagon, resulting in greater protection from...

2014-06-02 08:31:10

FDA-Approved CPR RsQ Assist® Makes It Easier for Anyone to Perform Hands-Only CPR MILWAUKEE, June 2, 2014 /PRNewswire/ -- Imagine having to perform CPR on a friend, loved one or stranger. One in four Americans say they've been in that situation, however most (70%) feel helpless to act during a cardiac emergency because they don't know what to do, or their training has significantly lapsed.(i) CPR RsQ Assist® - introduced by CPR RsQ Assist, Inc. - is a first-of-its-kind,...

2014-06-02 08:29:17

-- Omeros to Host Conference Call Today at 4:30 p.m. ET -- SEATTLE, June 2, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved Omidria(TM) (phenylephrine and ketorolac injection) 1%/0.3% for use during cataract surgery or intraocular lens replacement (ILR) to maintain pupil size by preventing intraoperative miosis (pupil constriction) and to reduce postoperative pain. The approval comes with no...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.